1-3 of 3
Jeffrey W. Tyner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Luxeptinib (CG-806) targets FLT3 and clusters of kinases operative in acute myeloid leukemia

William G. Rice, Stephen B. Howell, Hongying Zhang, Nasrin Rastgoo, Andrea Local, Stephen E. Kurtz, Pierrette Lo, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Brian J. Druker, Jeffrey W. Tyner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther molcanther.0832.2021.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0832
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract PR07: Novel oncogenic mutations in the beta subunit of heteromeric G-proteins identified by functional cDNA library screening.

Akinori Yoda, Guillaume Adelmant, Nobuaki Shindoh, Bjoern Chapuy, Yuka Yoda, Oliver Weigert, Nadja Kopp, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Jeffrey W. Tyner, Jason Gotlib, Michael W. Deininger, Shannon Turley, Jarrod A. Marto, Andrew A. Lane, David M. Weinstock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): PR07.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-PR07
Published: 01 November 2013
View article
Journal Articles

Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies

Joseph M. Gozgit, Matthew J. Wong, Scott Wardwell, Jeffrey W. Tyner, Marc M. Loriaux, Qurish K. Mohemmad, Narayana I. Narasimhan, William C. Shakespeare, Frank Wang, Brian J. Druker, Tim Clackson, Victor M. Rivera
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 1028–1035.
DOI: https://doi.org/10.1158/1535-7163.MCT-10-1044
Published: 08 June 2011
View article
PDF